August 19, 2008

PanGenex (PGXC) to Showcase Product Line and Resale Platform at the Florida Chiropractic Association National Convention and Expo

PanGenex Corporation (Pink Sheets: PGXC) will be hosting a product showcase at the Florida Chiropractic Association National Convention and Expo from August 21st thru August 24th. Practitioners and distributors visiting from around the country can visit PanGenex at booth #1204 at the Gaylord Palms Resort and Convention Center in Kissimmee, Florida. Showcase highlights will include complimentary cholesterol screening, testimonies from existing practitioners and a product exhibition that highlights the importance of Omega-3s and Omega-3 fish oils from fatty fish such as sardines and anchovies and that they have been proven to lower triglycerides and reduce the risk of sudden death by cardiac arrest by between 50-70% per the American Heart Association. LIPIDEME(TM) and Omeganol(TM), core products of the PanGenex product line, contain the purest Omega-3s available without a prescription and can be key elements in the battle against cholesterol and sudden cardiac arrest.

"We anticipate a positive response from our efforts at the FCA National Convention and Expo. Practitioners of all professions are continually seeking ways to enhance their practice through nutraceutical sales. The PanGenex product line gives practitioners the ability to offer pharmaceutical grade product solutions with tremendous wellness benefits," states Jeff Roman, President and CEO of PanGenex.

About PanGenex Corporation:

PanGenex is a publicly traded corporation (PINK SHEETS: PGXC) and pursues business opportunities in the $70 billion dollar nutraceutical and dietary supplement industry. With a focus on the cardiovascular health segment, PanGenex develops and markets sector leading, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products. Each product is scientifically formulated to address specific health conditions. Many of our products contain the purest grade of nutraceutical components available anywhere without a prescription. PanGenex markets products through healthcare practitioners, retail establishments and the internet on websites such as, and



This press release contains "forward-looking statements," which are statements related to future, not past, events. In this context, the forward-looking statements often include statements regarding our goals, plans, projections and guidance regarding our financial position, results of operations, market position, pending and potential future acquisitions and business strategy, and often contain words such as "expects,""anticipates,""intends,""plans,""believes,""seeks" or "will." Any such forward-looking statements are not assurances of future performance and involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. These risks and uncertainties include, among other things, (a) general economic and business conditions, (b) the level of strategic partner incentives, (c) the future regulatory environment, (d) our cost of financing, (e) our ability to complete acquisitions and dispositions and the risks associated therewith, and (f) our ability to retain key personnel. These factors, as well as additional factors, could affect our forward-looking statements. We urge you to carefully consider this information. We undertake no duty to update our forward-looking statements, including our earnings outlook. The statements in this press release have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.